Tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-3 in Japanese healthy children and in Kawasaki disease and their clinical usefulness in juvenile rheumatoid arthritis

Pediatrics International

Volumn 41, Issue 3, 1999, Pages 239-245

  Matsuyama, Tsuyoshi ^a  

^a NONE   (Japan)

Author keywords

Juvenile rheumatoid arthritis; Matrix metalloproteinase 3; Tissue inhibitor of metalloproteinases 1

Indexed keywords

C REACTIVE PROTEIN; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; ENZYME ASSAY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INFANT; JOINT DEGENERATION; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; MALE; MATRIX METALLOPROTEINASE 3; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROGNOSIS; PROTEASE INHIBITORS; REPRODUCIBILITY OF RESULTS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0033017378     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200x.1999.01061.x     Document Type: Article

References (23)

1. 1 Werb Z. The biologic role of metalloproteinases and their inhibitors. In: Kuettner KE, Schleyerbach R, Peyron JG, Hascall VC, eds. Articular Cartilage and Osteoarthritis. Raven Press Ltd, New York, 1992; 295-304.
2. 2 Robinson DR. Mediators of inflammation. In: Schumachar Jr HR, ed. Primer on the Rheumatic Diseases, 9th edn. The Arthritis Foundation, Atlanta, 1988; 24-30.
3. 3 Smith GW, Goetz TL, Anthony RV, Smith MF. Molecular cloning of an ovine ovarian tissue inhibitor of metalloproteinases: Ontogeny of messenger ribonucleic acid expression and in situ localization within preovulatory follicles and luteal tissue. Endocrinology 1994; 134: 344-52.
4. 4 Millis AJT, Hoyle M, McCue HM, Martini H. Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp. Cell Res. 1992; 201: 373-9.
5. 5 Lohmander LS, Hoerrner LA, Dahlberg L, Roos H, Bjornsson S, Lark MW. Stromelysin, tissue inhibitor of metalloproteinases and proteoglycan fragments in human knee joint fluid after injury. J. Rheumatol. 1993; 20: 1362-8.
6. 6 Sawai T, Uzuki M, Takahashi Y, Maeda S. Dynamics and distribution of matrix metalloproteinases and inhibitor of metalloproteinases in rheumatoid arthritis. Clin. Immunol. 1993; 25: 346-54.
7. 7 Roughley PJ, Nguyen Q, Mort JS. The role of proteinases and oxygen radicals in degradation of human articular cartilage. In: Kuettner KE, Schleyerbach R, Peyron JG, Hascall VC, eds. Articular Cartilage and Osteoarthritis. Raven Press Ltd, New York, 1992; 305-15.
8. 8 Pelletier JM, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab. Invest. 1994; 70: 807-15.
9. 9 Mizel SB, Dayer JM, Krane SM, Mergenhagen SE. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte activating factor (interleukin 1). Immunology 1981; 78: 2474-7.
10. 10 Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): Correlation with rheumatoid arthritis. Ann. Rheum. Dis. 1989; 48: 645-53.
11. 11 Shingu M, Obata K, Ezaki I et al. Stromelysin-1 (MMP-3) level in sera from patients with rheumatoid arthritis and other connective tissue diseases. Ryumachi 1995; 35: 15-24 (in Japanese).
12. 12 Hayakawa T, Yamashita K, Kodama S, Iwata H, Iwata K. Tissue inhibitor of metalloproteinases and collagenase activity in synovial fluid of human rheumatoid arthritis. Biomed. Res. 1991; 12: 169-73.
13. 13 Fukuda Y, Imoto M, Koyama Y et al. Immunohistochemical study on tissue inhibitors of metalloproteinases in normal and pathological human livers. Gastroenterol. Jap. 1991; 26: 37-41.
14. 14 Hayakawa T. Matrix metalloprotease inhibitor. In: Hayakawa T, ed. Proteases and Their Inhibitors. Medikalu View Sha Ltd, Tokyo, 1993; 117-25 (in Japanese).
15. 15 Ihsiguro N, Ito T, Obata K et al. Determination of stromelysin-1, 72 and 92 kDa type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. J. Rheumatol. 1996; 23: 1599-604.
16. 16 Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. J. Immunol. Methods 1990; 127: 103-8.
17. 17 Obata K, Iwata K, Okada Y et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinases 3 (stromelysin-1) using monoclonal antibodies. Clini. Chim. Acta 1992; 211: 59-72.
18. 18 Yoshihara Y, Obata K, Fujimoto N et al. Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38: 969-75.
19. 19 Terawaki T. Clinical study of juvenile rheumatoid arthritis. J. Jpn. Pediatr. Soc. 1981; 85: 801-2 (in Japanese).
20. 20 Watanabe N. Arthritis in Kawasaki disease. Rheumatology 1992; 8: 113-18 (in Japanese).
21. 21 Cassidy JT, Levinson JE, Bass JC et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum. 1986; 29: 274-81.
22. 22 White P. Juvenile chronic arthritis. In: Klippel JH, Dieppe PA, eds. Rheumatology. Mosby, London, 1994; 17.1-10.
23. 23 Cassidy JT, Petty RE. Juvenile rheumatoid arthritis. In: Cassidy JT, Petty RE (eds). Textbook of Pediatric Rheumatology, 3rd edn. WB Saunders, Philadelphia, 1992; 133-223.